SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-066181
Filing Date
2021-05-14
Accepted
2021-05-13 20:30:14
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2114120d1_10q.htm 10-Q 448325
2 EXHIBIT 31.1 tm2114120d1_ex31-1.htm EX-31.1 15946
3 EXHIBIT 31.2 tm2114120d1_ex31-2.htm EX-31.2 15692
4 EXHIBIT 32.1 tm2114120d1_ex32-1.htm EX-32.1 9656
  Complete submission text file 0001104659-21-066181.txt   3791129

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nbse-20210331.xml EX-101.INS 920007
6 XBRL TAXONOMY EXTENSION SCHEMA nbse-20210331.xsd EX-101.SCH 32197
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbse-20210331_cal.xml EX-101.CAL 36761
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbse-20210331_def.xml EX-101.DEF 83935
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20210331_lab.xml EX-101.LAB 323464
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20210331_pre.xml EX-101.PRE 228392
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 21921545
SIC: 2834 Pharmaceutical Preparations